Journal
CHEMBIOCHEM
Volume 15, Issue 9, Pages 1317-1324Publisher
WILEY-V C H VERLAG GMBH
DOI: 10.1002/cbic.201402010
Keywords
cell recognition; fluorescent probes; kinase inhibitors; proteins; signal transduction
Funding
- NIH/NCI grant [U54 CA156732]
- NIH/NIAID [AI076442]
Ask authors/readers for more resources
Many biological experiments are not compatible with the use of immunofluorescence, genetically encoded fluorescent tags, or FRET-based reporters. Conjugation of existing kinase inhibitors to cell-permeable fluorophores can provide a generalized approach to develop fluorescent probes of intracellular kinases. Here, we report the development of a small molecule probe of Src through conjugation of BODIPY to two well-established dual Src-Abl kinase inhibitors, dasatinib and saracatinib. We show that this approach is not successful for saracatinib but that dasatinib-BODIPY largely retains the biological activity of its parent compound and can be used to monitor the presence of Src kinase in individual cells by flow cytometry. It can also be used to track the localization of Src by fixed and live-cell fluorescence microscopy. This strategy could enable generation of additional kinase-specific probes useful in systems not amenable to genetic manipulation or could be used together with fluorescent proteins to enable a multiplexed assay readout.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available